Evidence Synthesis
THYROCARE has accelerated its 54.96% gross margin, up from 26.99% in its last quarterly reading.
Loading stock analysis…
Loading stock analysis…
Evidence Synthesis
Last synthesized: 18 Sept 2026, 04:47
See how this stock's evidence score moved across recent sessions — unlock Pro for the live chart.
Full momentum history unlocks with Pro or Research.
Evidence Synthesis
THYROCARE has accelerated its 54.96% gross margin, up from 26.99% in its last quarterly reading.
Source observations behind the synthesis narrative.
| Metric | Value | Trend | |
|---|---|---|---|
| GROSS_MARGIN | 54.96 % | 26.99 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | 26.99 % | 20.13 | ▲ |
| REVENUE_GROWTH_YOY | 24.3 % | 31.8 | ▼ |
| EPS_ACTUAL | 2.115 INR | 2.98 | ▼ |
| EPS_SURPRISE_PERCENT | 0.113 % | -0.448 | ▲ |
| PRICE_CHANGE_PERCENT | 3.316 % | — | - |
| DAILY_VOLUME | 1,45,352 shares | 7,57,601 | ▼ |
| CLOSE_PRICE | 559.25 INR | 541.3 | ▲ |
| NEWS_SENTIMENT_SCORE | 1 score | — | - |
| ANALYST_STRONG_BUY_COUNT | 0 count | 5 | ▼ |
| TARGET_PRICE_PREMIUM | 19.98 % | — | - |